The Galen Centre for Health and Social Policy will be organising a roundtable discussion with multi-sectoral stakeholders to deliberate on the rising healthcare costs in Malaysia.
In August 2018, the government repeated its concern of the escalating cost of healthcare in the country. Medical inflation was 12.7 percent in 2017 and projected to have been around 17 percent last year.
One aspect under scrutiny are the prices of pharmaceutical products, specifically drugs and medicines. A price control mechanism for these products is currently under serious consideration for imposition in 2019. Other issues being deliberated are private hospital fees, cost of medical devices and increasing health premiums.
This roundtable discussion aims to provide a platform for stakeholders to discuss and to understand how a multi-sectoral approach could be utilised to respond to this challenge.
Attendees will include representatives from relevant government ministries, pharmaceutical and healthcare technology industry, insurance and academia.